Applications of Gene Therapy - Challenges in Delivery of Therapeutic Genomics and Proteomics - page 312

[161] Rich DP, Anderson MP, Gregory RJ. Expression of cystic fibrosis transmembrane con-
ductance regulator corrects defective chloride regulation in cystic fibrosis airway epi-
thelial cells. Nature 1990;347:358-63.
[162] Mittereder N, Yei S, Bachurski C, Cuppoletti J, Whitsett JA, Tolstoshev P, et al. Evaluation
of the efficacy and safety of in vitro , adenovirusmediated transfer of the human cystic
fibrosis transmembrane conductance regulator cDNA. Hum Gene Ther 1994;5:719-31.
[163] Zabner J, Couture LA, Smith AE, Welsh MJ. Correction of cAMP stimulated fluid
secretion in cystic fibrosis airway epithelia: efficiency of adenovirus-mediated gene
transfer in vitro . Hum Gene Ther 1994;5:585-93.
[164] Montier T, Delepine P, Pichon C, Ferec C, Porteous DJ, Midoux P. Non-viral vectors
in cystic fibrosis gene therapy: progress and challenges. Trends Biotechnol 2004;22:
586-92.
[165] Rosenfeld MA, Yoshimura K, Trapnell BC, Yoneyama K, Rosenthal ER, Dalemans W,
et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator
gene to the airway epithelium. Cell 1992;68:143-55.
[166] Scaria A St., George JA, Jiang C, Kaplan JM, Wadsworth SC, Gregory RJ. Adenovirus-
mediated persistent cystic fibrosis transmembrane conductance regulator expression in
mouse airway epithelium. J Virol 1998;72:7302-9.
[167] Brody SL, Metzger M, Danel C, Rosenfeld MA, Crystal RG. Acute response of non-
human primates to airway delivery of an adenovirus vector containing the human cystic
fibrosis transmembrane conductance regulator cDNA. Hum Gene Ther 1994;5:8821-36.
[168] Grubb BR, Pickles RJ, Ye H, Yankaskas JR, Vick RN, Engelhardt JF, et al. Inefficient
gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans.
Nature 1994;371:802-6.
[169] Yang Y, Nunes FA, Berencsi K, Gonczol E, Engelhardt JF, Wilson JM. Inactivation of
E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibro-
sis. Nat Genet 1994;7:362-9.
[170] Flotte TR, Afione SA, Conrad C, McGrath SA, Solow R, Oka H, et al. Stable in vivo
expression of the cystic fibrosis transmembrane conductance regulator with an adeno-
associated virus vector. Proc Natl Acad Sci USA 1993;90:10613-17.
[171] Yoshimura K, Rosenfeld MA, Nakamura H, Scherer EM, Pavirani A, Lecocq JP, et al.
Expression of the human cystic fibrosis transmembrane conductance regulator gene in
the mouse lung after in vivo intratracheal plasmid-mediated gene transfer. Nucl Acids
Res 1992;20:3233-40.
[172] Snouwaert JN, Brigman KK, Latour AM, Iraj E, Schwab U, Gilmour MI, et al. A
murine model of cystic fibrosis. Am J Respir Crit Care Med 1995;151:S59-64.
[173] Hyde SC, Hyde SC, Gill DR, Higgins CF, Trezise AE, MacVinish LJ, et al. Correction
of the ion transport defect in cystic fibrosis transgenic mice by gene therapy. Nature
1993;362:250-5.
[174] Alton EW, Middleton PG, Caplen NJ, Smith SN, Steel DM, Munkonge FM, et al. Non-
invasive liposome-mediated gene delivery can correct the ion transport defect in cystic
fibrosis mutant mice. Nat Genet 1993;5:135-42.
[175] McLachlan G, Ho LP, Davidson-Smith H, Samways J, Davidson H, Stevenson BJ, et al.
Laboratory and clinical studies in support of cystic fibrosis gene therapy using pCMV-
CFTR -DOTAP. Gene Ther 1996;3:1113-23.
[176] Zabner J, Couture LA, Gregory RJ, Graham SM, Smith AE, Welsh MJ. Adenovirus-
mediated gene transfer transiently corrects the chloride transport defect in nasal epithe-
lia of patients with cystic fibrosis. Cell 1993;75:207-16.